Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
Titel:
Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study
Auteur:
Cheng, Ying Pan, Zhanyu Wu, Lin Zhu, Bo Yu, Yan Zang, Kai Zhuang, Wu Liu, Lianke Gu, Kangsheng Lian, Juanwen Chen, Rixin Bian, Tao Lin, Dang Sun, Shenghua Li, Wei Hang, Xiaosheng Jiang, Ou Zhong, Fukuan Wang, Rui Luo, Hui Shi, Huaqiu Wei, Zonghui Zhao, Li Chen, Shaoshui Sun, Hongmei Li, Xingya Sun, Debin Ren, Tiejun Lei, Kaijian He, Miao Li, Gaofeng Liu, Hailong Li, Runpu Hu, Chunhong Kong, Li Sun, Meili Xie, Liangzhi Gai, Wenlin Chen, Weiqiu Huang, Zhe Ren, Wenwen Su, Huo